T. Bryan Baldasare's most recent trade in InMed Pharmaceuticals Inc was a trade of 550 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 20, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
InMed Pharmaceuticals Inc | T. Bryan Baldasare | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 550 | 975 | - | - | Employee Stock Option (Right to Buy) | |
InMed Pharmaceuticals Inc | Baldasare T. Bryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2023 | 7,100 | 8,500 | - | - | Employee Stock Option (Right to Buy) | |
InMed Pharmaceuticals Inc | Bryan T. Baldasare | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 840 | 1,400 | - | - | Employee Stock Option (Right to Buy) | |
InMed Pharmaceuticals Inc | Bryan T. Baldasare | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2022 | 14,000 | 14,000 | - | - | Employee Stock Option (Right to Buy) |